Hylton NM - Search Results

1

Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial.

Onishi N, Li W, Gibbs J, Wilmes LJ, Nguyen A, Jones EF, Arasu V, Kornak J, Joe BN, Esserman LJ, Newitt DC, Hylton NM. Onishi N, et al. Among authors: hylton nm. Tomography. 2020 Jun;6(2):77-85. doi: 10.18383/j.tom.2020.00006. Tomography. 2020. PMID: 32548283 Free PMC article.

2

Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging.

Esserman L, Hylton N, Yassa L, Barclay J, Frankel S, Sickles E. Esserman L, et al. J Clin Oncol. 1999 Jan;17(1):110-9. doi: 10.1200/JCO.1999.17.1.110. J Clin Oncol. 1999. PMID: 10458224

3

Semi-automated analysis for MRI of breast tumors.

Partridge SC, Heumann EJ, Hylton NM. Partridge SC, et al. Among authors: hylton nm. Stud Health Technol Inform. 1999;62:259-60. Stud Health Technol Inform. 1999. PMID: 10538368

4

Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability.

Kinkel K, Helbich TH, Esserman LJ, Barclay J, Schwerin EH, Sickles EA, Hylton NM. Kinkel K, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2000 Jul;175(1):35-43. doi: 10.2214/ajr.175.1.1750035. AJR Am J Roentgenol. 2000. PMID: 10882243

5

MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging.

Frei KA, Kinkel K, Bonel HM, Lu Y, Esserman LJ, Hylton NM. Frei KA, et al. Among authors: hylton nm. AJR Am J Roentgenol. 2000 Dec;175(6):1577-84. doi: 10.2214/ajr.175.6.1751577. AJR Am J Roentgenol. 2000. PMID: 11090379

6

Integration of breast imaging into cancer management.

Esserman LJ, Wolverton D, Hylton N. Esserman LJ, et al. Curr Oncol Rep. 2000 Nov;2(6):572-81. doi: 10.1007/s11912-000-0112-y. Curr Oncol Rep. 2000. PMID: 11122895 Review.

7

Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor Histopathology and Angiogenesis in Breast Carcinoma.

Esserman L, Hylton N, George T, Weidner N. Esserman L, et al. Breast J. 1999 Jan;5(1):13-21. doi: 10.1046/j.1524-4741.1999.005001013.x. Breast J. 1999. PMID: 11348250

8

Challenges to interpretation of breast MRI.

Kinkel K, Hylton NM. Kinkel K, et al. Among authors: hylton nm. J Magn Reson Imaging. 2001 Jun;13(6):821-9. doi: 10.1002/jmri.1117. J Magn Reson Imaging. 2001. PMID: 11382939 Review.

9

MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.

Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. Esserman L, et al. Ann Surg Oncol. 2001 Jul;8(6):549-59. doi: 10.1007/s10434-001-0549-8. Ann Surg Oncol. 2001. PMID: 11456056

10

Magnetic resonance imaging for primary breast cancer management: current role and new applications.

Esserman L, Wolverton D, Hylton N. Esserman L, et al. Endocr Relat Cancer. 2002 Jun;9(2):141-53. doi: 10.1677/erc.0.0090141. Endocr Relat Cancer. 2002. PMID: 12121836 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters